Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: Nat Med. 2020 Feb 17;26(4):529–534. doi: 10.1038/s41591-020-0770-2

Extended Data Fig. 3 |. 11C-Rifampin measurements in the liver and brain of TB patients.

Extended Data Fig. 3 |

(a) Time-activity curve of 11C-rifampin measured in the liver of patients. (b) AUC liver to plasma ratios (c) Time-activity curve of 11C-rifampin measured in the brain of patients. (d) AUC brain to plasma ratios. The red dots represent individual measurements [n = 12 VOIs (measured at 10 time-points; total 120 VOIs per organ) corresponding to the 12 patients], with the black line and grey region representing the median and interquartile range, respectively. Tissue to plasma AUCs are represented as median and interquartile range.